Flutemetamol

DB15058InvestigationalSmall molecule

Flutemetamol is under investigation in clinical trial NCT02353949 (Investigating the Clinical Consequences of Flutemetamol-PET-scanning).

Mechanism: Pharmacologically active on Amyloid-beta precursor protein
Curator reviewed
Formula / weight: C₁₄H₁₁FN₂OS · 274.31 g/mol (avg)

Resolves to

Compound

Clinical / RWD

Structure

InChIKeyVVECGOCJFKTUAX-UHFFFAOYSA-NSMILESCNC1=C(F)C=C(C=C1)C1=NC2=C(S1)C=C(O)C=C2

Targets

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

14Clinical trialsPhase, status and sponsor resolved per trial

1Marketed productAcross 1 country and 1 labeller

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with Flutemetamol, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.